nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Tension—Lisinopril—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Hydroxychloroquine—Skin disorder—Azathioprine—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Hydroxychloroquine—Nervousness—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Hydroxychloroquine—Affect lability—Prednisone—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Hydroxychloroquine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Hydroxychloroquine—Vomiting—Pentoxifylline—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Hydroxychloroquine—Psychotic disorder—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Hydroxychloroquine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Hydroxychloroquine—Rash—Pentoxifylline—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Hydroxychloroquine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Hydroxychloroquine—Headache—Pentoxifylline—systemic scleroderma	0.00146	0.00147	CcSEcCtD
Hydroxychloroquine—Vision blurred—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Captopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Hydroxychloroquine—Asthenia—Mometasone—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Hydroxychloroquine—Irritability—Prednisone—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Hydroxychloroquine—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Methotrexate—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Hydroxychloroquine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Hydroxychloroquine—Mood swings—Prednisone—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Hydroxychloroquine—Pruritus—Mometasone—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Hydroxychloroquine—Anaemia—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Hydroxychloroquine—Skin disorder—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Hydroxychloroquine—Angioedema—Lisinopril—systemic scleroderma	0.0014	0.00141	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Captopril—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Captopril—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Hydroxychloroquine—Oedema—Mycophenolic acid—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Hydroxychloroquine—Anorexia—Leflunomide—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Hydroxychloroquine—Nausea—Pentoxifylline—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Hydroxychloroquine—Vertigo—Lisinopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mometasone—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Hydroxychloroquine—Leukopenia—Lisinopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Hydroxychloroquine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Hydroxychloroquine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Hydroxychloroquine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Hydroxychloroquine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Prednisone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00133	0.00134	CcSEcCtD
Hydroxychloroquine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Hydroxychloroquine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Hydroxychloroquine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Hydroxychloroquine—Vomiting—Mometasone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Hydroxychloroquine—Rash—Mometasone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Hydroxychloroquine—Asthenia—Captopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mometasone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Hydroxychloroquine—Headache—Mometasone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Hydroxychloroquine—Fatigue—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Hydroxychloroquine—Oedema—Lisinopril—systemic scleroderma	0.00125	0.00126	CcSEcCtD
Hydroxychloroquine—Pruritus—Captopril—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Hydroxychloroquine—Pain—Leflunomide—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Hydroxychloroquine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Hydroxychloroquine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Hydroxychloroquine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Hydroxychloroquine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Azathioprine—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Azathioprine—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Hydroxychloroquine—Skin disorder—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Captopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hydroxychloroquine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hydroxychloroquine—Irritability—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hydroxychloroquine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hydroxychloroquine—Fatigue—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hydroxychloroquine—Mood swings—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hydroxychloroquine—Nausea—Mometasone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hydroxychloroquine—Anorexia—Lisinopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hydroxychloroquine—Ataxia—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hydroxychloroquine—Pain—Mycophenolic acid—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hydroxychloroquine—Weight decreased—Prednisone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Hydroxychloroquine—Dizziness—Captopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Hydroxychloroquine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Hydroxychloroquine—Depression—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Hydroxychloroquine—Urticaria—Leflunomide—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Leflunomide—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Leflunomide—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hydroxychloroquine—Vomiting—Captopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Hydroxychloroquine—Rash—Captopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Hydroxychloroquine—Dermatitis—Captopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Hydroxychloroquine—Somnolence—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Hydroxychloroquine—Headache—Captopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Hydroxychloroquine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hydroxychloroquine—Fatigue—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hydroxychloroquine—Pain—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Hydroxychloroquine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Azathioprine—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Hydroxychloroquine—Nausea—Captopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Hydroxychloroquine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Hydroxychloroquine—Asthenia—Leflunomide—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Hydroxychloroquine—Pruritus—Leflunomide—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Hydroxychloroquine—Dizziness—Azathioprine—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.001	0.001	CcSEcCtD
Hydroxychloroquine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000999	0.001	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Leflunomide—systemic scleroderma	0.000999	0.001	CcSEcCtD
Hydroxychloroquine—Urticaria—Lisinopril—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Lisinopril—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Lisinopril—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Hydroxychloroquine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000986	0.000986	CcSEcCtD
Hydroxychloroquine—Vomiting—Azathioprine—systemic scleroderma	0.000983	0.000984	CcSEcCtD
Hydroxychloroquine—Eye disorder—Prednisone—systemic scleroderma	0.00098	0.000981	CcSEcCtD
Hydroxychloroquine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000977	0.000978	CcSEcCtD
Hydroxychloroquine—Drowsiness—Methotrexate—systemic scleroderma	0.000977	0.000977	CcSEcCtD
Hydroxychloroquine—Rash—Azathioprine—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Hydroxychloroquine—Dermatitis—Azathioprine—systemic scleroderma	0.000974	0.000974	CcSEcCtD
Hydroxychloroquine—Depression—Methotrexate—systemic scleroderma	0.000974	0.000974	CcSEcCtD
Hydroxychloroquine—Headache—Azathioprine—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Hydroxychloroquine—Dizziness—Leflunomide—systemic scleroderma	0.000966	0.000966	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000953	0.000954	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000949	0.000949	CcSEcCtD
Hydroxychloroquine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00094	0.00094	CcSEcCtD
Hydroxychloroquine—Vomiting—Leflunomide—systemic scleroderma	0.000928	0.000929	CcSEcCtD
Hydroxychloroquine—Alopecia—Prednisone—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000924	0.000925	CcSEcCtD
Hydroxychloroquine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000921	0.000922	CcSEcCtD
Hydroxychloroquine—Rash—Leflunomide—systemic scleroderma	0.000921	0.000921	CcSEcCtD
Hydroxychloroquine—Dermatitis—Leflunomide—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Hydroxychloroquine—Mental disorder—Prednisone—systemic scleroderma	0.000919	0.000919	CcSEcCtD
Hydroxychloroquine—Nausea—Azathioprine—systemic scleroderma	0.000918	0.000919	CcSEcCtD
Hydroxychloroquine—Headache—Leflunomide—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Hydroxychloroquine—Malnutrition—Prednisone—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000911	0.000912	CcSEcCtD
Hydroxychloroquine—Asthenia—Lisinopril—systemic scleroderma	0.0009	0.000901	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Hydroxychloroquine—Pruritus—Lisinopril—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Hydroxychloroquine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000886	0.000886	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Methotrexate—systemic scleroderma	0.000881	0.000881	CcSEcCtD
Hydroxychloroquine—Rash—Mycophenolic acid—systemic scleroderma	0.000878	0.000879	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000878	0.000878	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Methotrexate—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Hydroxychloroquine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000873	0.000874	CcSEcCtD
Hydroxychloroquine—Headache—Mycophenolic acid—systemic scleroderma	0.000873	0.000873	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Hydroxychloroquine—Nausea—Leflunomide—systemic scleroderma	0.000867	0.000868	CcSEcCtD
Hydroxychloroquine—Vision blurred—Prednisone—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Lisinopril—systemic scleroderma	0.000859	0.000859	CcSEcCtD
Hydroxychloroquine—Visual impairment—Methotrexate—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Hydroxychloroquine—Anaemia—Prednisone—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Hydroxychloroquine—Agitation—Prednisone—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Hydroxychloroquine—Angioedema—Prednisone—systemic scleroderma	0.000834	0.000835	CcSEcCtD
Hydroxychloroquine—Dizziness—Lisinopril—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Hydroxychloroquine—Nausea—Mycophenolic acid—systemic scleroderma	0.000827	0.000828	CcSEcCtD
Hydroxychloroquine—Vertigo—Prednisone—systemic scleroderma	0.00082	0.000821	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methotrexate—systemic scleroderma	0.000819	0.00082	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—systemic scleroderma	0.000817	0.000818	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Prednisone—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Hydroxychloroquine—Vomiting—Lisinopril—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Hydroxychloroquine—Rash—Lisinopril—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Hydroxychloroquine—Convulsion—Prednisone—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Hydroxychloroquine—Dermatitis—Lisinopril—systemic scleroderma	0.00079	0.000791	CcSEcCtD
Hydroxychloroquine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Hydroxychloroquine—Headache—Lisinopril—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Hydroxychloroquine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Hydroxychloroquine—Alopecia—Methotrexate—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Hydroxychloroquine—Mental disorder—Methotrexate—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methotrexate—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Hydroxychloroquine—Nausea—Lisinopril—systemic scleroderma	0.000745	0.000746	CcSEcCtD
Hydroxychloroquine—Oedema—Prednisone—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Prednisone—systemic scleroderma	0.000731	0.000731	CcSEcCtD
Hydroxychloroquine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Hydroxychloroquine—Skin disorder—Prednisone—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Hydroxychloroquine—Vision blurred—Methotrexate—systemic scleroderma	0.000719	0.000719	CcSEcCtD
Hydroxychloroquine—Anorexia—Prednisone—systemic scleroderma	0.00071	0.000711	CcSEcCtD
Hydroxychloroquine—Anaemia—Methotrexate—systemic scleroderma	0.000705	0.000706	CcSEcCtD
Hydroxychloroquine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Hydroxychloroquine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Hydroxychloroquine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Hydroxychloroquine—Vertigo—Methotrexate—systemic scleroderma	0.000686	0.000686	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methotrexate—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Hydroxychloroquine—Convulsion—Methotrexate—systemic scleroderma	0.000661	0.000661	CcSEcCtD
Hydroxychloroquine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Prednisone—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Hydroxychloroquine—Fatigue—Prednisone—systemic scleroderma	0.000642	0.000643	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000609	0.00061	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methotrexate—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisone—systemic scleroderma	0.000592	0.000592	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Prednisone—systemic scleroderma	0.000589	0.000589	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Prednisone—systemic scleroderma	0.000589	0.000589	CcSEcCtD
Hydroxychloroquine—Somnolence—Methotrexate—systemic scleroderma	0.000554	0.000554	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Prednisone—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Methotrexate—systemic scleroderma	0.000541	0.000542	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Hydroxychloroquine—Fatigue—Methotrexate—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Hydroxychloroquine—Asthenia—Prednisone—systemic scleroderma	0.000535	0.000535	CcSEcCtD
Hydroxychloroquine—Pain—Methotrexate—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Hydroxychloroquine—Pruritus—Prednisone—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Prednisone—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Hydroxychloroquine—Urticaria—Methotrexate—systemic scleroderma	0.000495	0.000495	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisone—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—systemic scleroderma	0.000492	0.000493	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methotrexate—systemic scleroderma	0.000492	0.000493	CcSEcCtD
Hydroxychloroquine—Vomiting—Prednisone—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Hydroxychloroquine—Rash—Prednisone—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisone—systemic scleroderma	0.000469	0.00047	CcSEcCtD
Hydroxychloroquine—Headache—Prednisone—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Hydroxychloroquine—Asthenia—Methotrexate—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisone—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Hydroxychloroquine—Pruritus—Methotrexate—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Methotrexate—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Hydroxychloroquine—Dizziness—Methotrexate—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Hydroxychloroquine—Vomiting—Methotrexate—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Hydroxychloroquine—Rash—Methotrexate—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Hydroxychloroquine—Headache—Methotrexate—systemic scleroderma	0.00039	0.00039	CcSEcCtD
Hydroxychloroquine—Nausea—Methotrexate—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	3.37e-05	0.0901	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	2.66e-05	0.0712	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	2.63e-05	0.0703	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	2.48e-05	0.0664	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	2.35e-05	0.0629	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	2.08e-05	0.0556	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	1.96e-05	0.0525	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	1.86e-05	0.0497	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	9.95e-06	0.0266	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—ITGAM—systemic scleroderma	8.04e-06	0.0215	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD247—systemic scleroderma	8.04e-06	0.0215	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	7.86e-06	0.021	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	7.76e-06	0.0208	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TNFAIP3—systemic scleroderma	7.53e-06	0.0201	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD247—systemic scleroderma	6.36e-06	0.017	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—ITGAM—systemic scleroderma	6.36e-06	0.017	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—EDN1—systemic scleroderma	6.24e-06	0.0167	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	6.14e-06	0.0164	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—TNFAIP3—systemic scleroderma	5.95e-06	0.0159	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CSK—systemic scleroderma	4.98e-06	0.0133	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IRF5—systemic scleroderma	4.9e-06	0.0131	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ITGAM—systemic scleroderma	4.68e-06	0.0125	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD247—systemic scleroderma	4.68e-06	0.0125	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IRF8—systemic scleroderma	4.68e-06	0.0125	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TNFAIP3—systemic scleroderma	4.39e-06	0.0117	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—BLK—systemic scleroderma	4.33e-06	0.0116	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CSK—systemic scleroderma	3.94e-06	0.0105	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IRF5—systemic scleroderma	3.87e-06	0.0104	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ITGAM—systemic scleroderma	3.7e-06	0.00991	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD247—systemic scleroderma	3.7e-06	0.00991	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IRF8—systemic scleroderma	3.7e-06	0.00991	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SMAD7—systemic scleroderma	3.61e-06	0.00967	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTLA4—systemic scleroderma	3.55e-06	0.0095	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TNFAIP3—systemic scleroderma	3.47e-06	0.00928	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BLK—systemic scleroderma	3.43e-06	0.00917	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-DQB1—systemic scleroderma	2.92e-06	0.00782	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTLA4—systemic scleroderma	2.81e-06	0.00751	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RHOB—systemic scleroderma	2.8e-06	0.00748	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1A—systemic scleroderma	2.78e-06	0.00743	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD40LG—systemic scleroderma	2.76e-06	0.00739	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HSPG2—systemic scleroderma	2.64e-06	0.00705	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CSK—systemic scleroderma	2.55e-06	0.00681	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-DQB1—systemic scleroderma	2.31e-06	0.00618	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1A—systemic scleroderma	2.2e-06	0.00587	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD40LG—systemic scleroderma	2.18e-06	0.00584	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1B—systemic scleroderma	1.45e-06	0.00387	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EDN1—systemic scleroderma	1.43e-06	0.00382	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1B—systemic scleroderma	1.14e-06	0.00306	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL2—systemic scleroderma	9.76e-07	0.00261	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOS3—systemic scleroderma	8.7e-07	0.00233	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—systemic scleroderma	6.98e-07	0.00187	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—systemic scleroderma	5.75e-07	0.00154	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	4.74e-07	0.00127	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CTGF—systemic scleroderma	3.59e-07	0.000962	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NOS3—systemic scleroderma	1.56e-07	0.000419	CbGpPWpGaD
